(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Inventory | -3.52%18.3B | -1.73%18.14B | 10.91%20.31B | 9.10%19.01B | -2.34%18.97B | -3.18%18.46B | -10.79%18.31B | 0.17%17.42B | 23.52%19.42B | 22.12%19.06B |
Developing and for sale properties | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Accounts receivable | 10.73%12.99B | 6.12%10.71B | 17.93%12.85B | 17.89%13.44B | 11.55%11.73B | 26.41%10.1B | 24.24%10.9B | 40.81%11.4B | 28.93%10.52B | 6.12%7.99B |
Notes receivable | -30.54%1.07B | -8.56%1.15B | -55.40%1.19B | -44.17%1.35B | -44.28%1.53B | -57.91%1.26B | -24.00%2.66B | -31.37%2.42B | -23.49%2.75B | -20.80%2.99B |
Insurance and other receivables-current assets | -26.94%482.43M | -18.95%412.07M | 15.60%706.96M | 1.77%607.01M | 8.49%660.33M | -16.30%508.41M | -19.18%611.57M | -34.02%596.45M | -0.75%608.65M | -4.10%607.44M |
Cash and equivalents | 12.95%17.32B | 13.84%17.13B | 24.86%17.55B | 39.17%18.42B | 0.67%15.33B | -19.63%15.05B | -22.59%14.06B | -48.70%13.24B | -37.80%15.23B | -29.84%18.72B |
Other current assets | 97.34%1.7B | 53.00%1.45B | -5.94%1.06B | 29.64%889.54M | 4.00%859.63M | 12.79%947.76M | 24.13%1.13B | -36.21%686.15M | -27.26%826.57M | -13.00%840.26M |
Special items of current assets | 5.02%5.95B | 20.18%18.78B | 41.78%7.84B | 40.85%8.22B | -25.32%5.66B | 94.68%15.62B | -27.44%5.53B | -1.31%5.83B | 28.06%7.58B | 34.44%8.03B |
Total current assets | 11.73%80.47B | 12.26%75.69B | 19.04%83.21B | 22.89%81.27B | 3.01%72.03B | -3.48%67.42B | -3.85%69.9B | -12.57%66.13B | -1.08%69.92B | -1.16%69.85B |
Non-current assets | ||||||||||
Fixed assets | 2.58%4.99B | 3.25%5.03B | 2.10%4.84B | 1.76%4.88B | 0.01%4.86B | -1.80%4.88B | -3.54%4.74B | -1.34%4.8B | -2.86%4.86B | -5.28%4.97B |
Investment property | -3.03%144.97M | -1.73%146.05M | -4.33%146.12M | -2.83%149.66M | -4.45%149.5M | -5.73%148.62M | 4.20%152.74M | 3.48%154.02M | -2.68%156.47M | -3.26%157.66M |
Construction in progress | 120.11%885.63M | 109.93%789.08M | 57.03%664.07M | 25.83%454.86M | 28.24%402.35M | 31.21%375.88M | 150.39%422.9M | 52.30%361.48M | 39.10%313.75M | 40.10%286.48M |
Long-term receivables | 25.78%207.52M | 15.08%201.49M | -76.61%263.44M | -84.09%167.41M | -78.08%164.99M | -68.30%175.09M | 238.09%1.13B | 398.00%1.05B | 210.53%752.84M | 101.59%552.28M |
Development expenditure | -78.31%4.66M | -10.82%4.68M | 416.31%29.46M | 343.88%24.91M | 308.72%21.47M | 22.97%5.25M | 104.68%5.71M | 173.51%5.61M | 155.99%5.25M | 108.11%4.27M |
long-term investment | -26.41%1.86B | -25.65%1.78B | 14.16%2.61B | 14.05%2.6B | 6.91%2.53B | 4.75%2.4B | 4.35%2.29B | 6.47%2.28B | 1.38%2.36B | 28.94%2.29B |
Intangible assets | 5.92%1.85B | 4.88%1.85B | 5.68%1.75B | 7.20%1.76B | 7.58%1.75B | 6.90%1.76B | 9.77%1.66B | 8.61%1.65B | 5.40%1.63B | 3.01%1.65B |
Goodwill | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred tax assets | 4.40%3.29B | 0.62%3.23B | 0.82%3.27B | -2.59%3.19B | 0.25%3.15B | 2.16%3.21B | 5.64%3.24B | 7.59%3.27B | 4.65%3.14B | 5.53%3.14B |
Other illiquid assets | 66.58%7.57B | 67.10%6.85B | 10.42%5.18B | 14.43%4.7B | 17.61%4.55B | 2.01%4.1B | 39.69%4.69B | 17.24%4.11B | 34.30%3.87B | 42.73%4.02B |
Special items of non-current assets | 12.40%6B | 23.04%5.97B | 29.24%5.58B | 18.44%5.63B | 45.26%5.34B | 39.53%4.85B | 58.62%4.32B | 113.19%4.75B | 79.60%3.68B | 65.85%3.47B |
Total non-current assets | 3.09%47.91B | -5.22%45.42B | 0.75%44.2B | 3.29%45.2B | 37.75%46.47B | 44.12%47.92B | 45.89%43.87B | 83.35%43.76B | 30.45%33.74B | 22.59%33.25B |
Total assets | 8.34%128.38B | 5.00%121.11B | 11.99%127.41B | 15.08%126.47B | 14.32%118.5B | 11.87%115.34B | 10.70%113.77B | 10.44%109.9B | 7.37%103.66B | 5.43%103.1B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Accounts payable | 6.24%21.65B | 11.25%19.31B | 21.77%22.39B | 23.96%20.69B | 27.71%20.38B | 24.32%17.35B | 13.53%18.39B | 11.01%16.69B | 30.73%15.96B | 2.33%13.96B |
Notes payable | 7.70%12.99B | 38.55%13.89B | 62.22%14.25B | 68.10%12.94B | 90.73%12.06B | 60.30%10.03B | 75.42%8.78B | 76.28%7.7B | 40.98%6.32B | 28.66%6.25B |
Tax payable | 77.11%609.37M | 32.86%439.79M | -27.57%477.92M | -33.69%400.16M | -30.69%344.06M | -24.92%331.02M | 138.65%659.8M | 86.99%603.45M | 248.90%496.4M | 52.86%440.92M |
Other payables and accrued expenses | 17.62%1.56B | 17.47%1.49B | -11.59%1.28B | 11.03%2.28B | -10.08%1.33B | -9.89%1.27B | -31.92%1.45B | -15.23%2.05B | -1.79%1.48B | -0.39%1.41B |
Advance payment | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Short-term borrowing | -27.68%90.17M | 6.71%110.17M | 7.60%120M | 154.00%127M | 101.64%124.67M | 146.80%103.24M | -66.73%111.53M | -84.26%50M | -79.51%61.83M | -85.96%41.83M |
Other current liabilities | 534.18%1.69B | 602.50%2.07B | -24.19%357.24M | -25.79%257.93M | -51.87%266.87M | -64.97%294.43M | 197.06%471.23M | 132.80%347.56M | 294.45%554.5M | 592.94%840.44M |
Special items of current liabilities | -12.27%4.73B | -69.76%1.77B | -36.91%4.45B | -3.74%7.4B | 20.17%5.4B | 26.64%5.86B | 7.98%7.05B | 16.60%7.69B | -32.00%4.49B | -29.46%4.63B |
Total current liabilities | 11.10%77.34B | 5.67%71.25B | 16.65%77.39B | 22.89%77.6B | 22.02%69.62B | 16.30%67.43B | 12.97%66.34B | 11.30%63.14B | 5.75%57.05B | 3.34%57.98B |
Net current assets | 29.85%3.13B | 97,607.86%4.44B | 63.74%5.82B | 22.94%3.67B | -81.27%2.41B | -100.04%-4.55M | -74.56%3.55B | -84.19%2.99B | -23.11%12.87B | -18.46%11.88B |
Total assets less current liabilities | 4.41%51.04B | 4.06%49.86B | 5.47%50.02B | 4.54%48.88B | 4.89%48.88B | 6.18%47.92B | 7.67%47.43B | 9.29%46.75B | 9.41%46.61B | 8.25%45.13B |
Non-current liabilities | ||||||||||
Long-term bank loan | 74.27%1.68B | 45.45%1.38B | -20.03%1.38B | -36.93%992.53M | -37.88%965.28M | -39.23%951.11M | 27.31%1.72B | 122.98%1.57B | 118.21%1.55B | 117.57%1.57B |
Long-term accounts payable | 0.00%240K | 0.00%240K | 0.00%240K | 0.00%240K | 0.00%240K | 0.00%240K | -95.78%240K | -95.78%240K | -95.76%240K | -95.76%240K |
Long-term remuneration payable to staff and workers | -4.17%1.07B | 0.55%1.05B | -1.96%1.13B | -1.39%1.12B | 0.14%1.11B | 7.06%1.05B | 3.79%1.15B | 2.92%1.14B | 1.12%1.11B | 1.84%978.7M |
Deferred tax liability | 195.58%183.24M | 44.89%180.16M | 15.43%50.38M | 15.43%50.38M | 27.73%61.99M | 170.54%124.34M | 1.90%43.65M | 27.01%43.65M | 41.23%48.53M | 33.74%45.96M |
Deferred income-non-current liabilities | -1.98%364.03M | 8.03%365.33M | 11.22%394.4M | 5.34%360.3M | 1.58%371.37M | -5.91%338.17M | -4.39%354.6M | -11.82%342.03M | -8.14%365.57M | -11.10%359.4M |
Issued debt instrument | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other non-current liabilities | --0 | ---- | ---- | ---- | --3.72M | ---- | ---- | ---- | ---- | ---- |
Special items of non-current liabilities | -17.39%5.49B | -17.04%5.66B | -5.29%6.36B | -6.48%6.55B | -5.56%6.64B | 0.34%6.82B | 11.28%6.71B | 17.06%7.01B | 17.96%7.03B | 14.71%6.8B |
Total non-current liabilities | -4.09%8.78B | -6.90%8.64B | -6.76%9.31B | -10.16%9.08B | -9.44%9.16B | -4.77%9.28B | 12.01%9.99B | 22.85%10.1B | 23.15%10.11B | 21.07%9.74B |
Total liabilities | 9.33%86.13B | 4.15%79.89B | 13.59%86.7B | 18.33%86.68B | 17.29%78.77B | 13.27%76.71B | 12.85%76.33B | 12.76%73.25B | 8.05%67.16B | 5.56%67.72B |
Total assets less total liabilities | 6.37%42.25B | 6.69%41.22B | 8.73%40.71B | 8.60%39.8B | 8.86%39.72B | 9.19%38.64B | 6.57%37.44B | 6.07%36.65B | 6.12%36.49B | 5.18%35.38B |
Total equity and non-current liabilities | 4.41%51.04B | 4.06%49.86B | 5.47%50.02B | 4.54%48.88B | 4.89%48.88B | 6.18%47.92B | 7.67%47.43B | 9.29%46.75B | 9.41%46.61B | 8.25%45.13B |
Equity | ||||||||||
Share capital | 0.00%3.12B | -0.01%3.12B | -0.01%3.12B | -0.01%3.12B | -0.02%3.12B | -0.01%3.12B | -0.01%3.12B | -0.02%3.12B | -0.02%3.12B | -0.02%3.12B |
Legal reserve | 11.29%1.34B | 11.29%1.34B | 10.54%1.2B | 10.54%1.2B | 10.54%1.2B | 10.54%1.2B | 11.73%1.09B | 11.73%1.09B | 11.73%1.09B | 11.73%1.09B |
Capital reserve | -0.67%11.57B | -0.73%11.57B | 1.66%11.6B | 1.33%11.57B | 0.89%11.64B | 1.81%11.65B | -1.48%11.41B | -1.43%11.42B | -0.37%11.54B | -1.21%11.44B |
Undistributed profit | 11.12%22.24B | 12.28%21.34B | 11.19%20.87B | 10.67%19.96B | 11.82%20.02B | 11.94%19B | 12.47%18.77B | 11.53%18.03B | 11.78%17.9B | 10.36%16.98B |
Special items of shareholders' rights and interests | -57.03%109.12M | -55.61%107.53M | -41.70%145.72M | -5.94%201.96M | 10.20%253.92M | 15.87%242.24M | 20.87%249.96M | 4.48%214.71M | 8.04%230.41M | 8.37%209.07M |
Shareholders' Equity | 5.94%38.15B | 6.44%37.24B | 6.69%36.71B | 6.49%35.83B | 7.37%36.01B | 7.68%34.99B | 6.76%34.41B | 6.11%33.64B | 6.28%33.54B | 5.14%32.5B |
Non-controlling interest | 10.53%4.1B | 9.10%3.97B | 31.90%3.99B | 32.21%3.97B | 25.83%3.71B | 26.24%3.64B | 4.45%3.03B | 5.62%3B | 4.37%2.95B | 5.57%2.89B |
Total equity | 6.37%42.25B | 6.69%41.22B | 8.73%40.71B | 8.60%39.8B | 8.86%39.72B | 9.19%38.64B | 6.57%37.44B | 6.07%36.65B | 6.12%36.49B | 5.18%35.38B |
Total equity and total liabilities | 8.34%128.38B | 5.00%121.11B | 11.99%127.41B | 15.08%126.47B | 14.32%118.5B | 11.87%115.34B | 10.70%113.77B | 10.44%109.9B | 7.37%103.66B | 5.43%103.1B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data